{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T05:13:57Z","timestamp":1718082837960},"reference-count":12,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T00:00:00Z","timestamp":1232582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> The purpose of this study was to determine the incidence and severity of epistaxis in patients treated with paclitaxel. Patients who were treated with paclitaxel filled a questionnaire regarding their general health, medications and incidents of epistaxis. Relevant clinical information was obtained from the patients\u2019 charts. Forty\u2010seven consecutive patients were recruited to the study. Twenty\u2010four (51%) of the patients reported epistaxis during paclitaxel therapy. Twenty\u2010three of 39 (59%) patients who received weekly paclitaxel had epistaxis at least once during treatment, compared with one out of eight patients who were treated every 3 weeks (P\u00a0=\u00a00.045). All episodes of epistaxis were mild, occurred with normal platelets counts and did not require blood product transfusions or treatment modification. The majority of the patients experienced the first episode of epistaxis on the third week of weekly paclitaxel treatment and then repeatedly throughout therapy. It is concluded that epistaxis is a common mild side\u2010effect of weekly paclitaxel that has not been reported previously. In this trial, epistaxis did not have any major clinical consequences. However, when paclitaxel is combined with other drugs that may cause bleeding, such as bevacizumab, physicians should be alerted to the potential risk of this phenomenon.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2008.00372.x","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T11:14:52Z","timestamp":1232622892000},"page":"259-261","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epistaxis during Treatment with Paclitaxel"],"prefix":"10.1111","volume":"104","author":[{"given":"Nirit","family":"Yarom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnoldo","family":"Cyjon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Kovel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelya","family":"Yachnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avishay","family":"Sella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Evron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.6699"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089160409000304"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.232"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(05)80069-1"},{"key":"e_1_2_5_6_2","first-page":"235","article-title":"Severe epistaxis and thrombocytopathy in oncology patient","volume":"9","author":"Patrocinio LG","year":"2005","journal-title":"Int Arch Otorhinolaringol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767140-00006"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2005.01.045"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2624"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1158\/1535-7163.1301.3.10","article-title":"Antiangiogenic activity of Paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway","volume":"3","author":"Pasquier E","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"e_1_2_5_11_2","first-page":"1843","article-title":"The microtubule\u2010affecting drug Paclitaxel has antiangiogenic activity","volume":"2","author":"Belotti D","year":"1996","journal-title":"Clin Cancer Res"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072113"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.6004\/jnccn.2007.0026","article-title":"Novel approaches to advanced breast cancer: Bevacizumab and Lapatinib","volume":"5","author":"Mayer EL","year":"2007","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2008.00372.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2008.00372.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:46:05Z","timestamp":1696985165000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2008.00372.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,12]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1742-7843.2008.00372.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2008.00372.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,12]]},"assertion":[{"value":"2009-02-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}